The Immunology and Biology of Brain Tumors

doi:10.3390/books978-3-0365-0103-1

Download Url(s)

https://mdpi.com/books/pdfview/book/3653

Contributor(s)

Graner, Michael (editor)

Language

English

Show full item record

Abstract

Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy.

URI

https://directory.doabooks.org/handle/20.500.12854/76275

Keywords

vaccine therapy; oncoantigen; tumor associate antigen; tumor angiogenesis; high-grade glioma; pituitary neuroendocrine tumors; VEGF; Treg; TAM; PD-1; PD-L1; tumor microenvironment (TME); glioblastoma multiforme (GBM); GBM-associated macrophages (GAMs); exosomes; oncomiR-21; STAT3 inhibitor; glioma; diffusion tensor imaging; generalized q-ball imaging; treatment-related effects; multiple resections; adrenal insufficiency; Addison’s disease; bevacizumab; cerebral radiation necrosis; craniopharyngioma; inflammation; checkpoint inhibitors; Interleukin-6